Annual report pursuant to Section 13 and 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.10.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Nov. 30, 2018
Nov. 30, 2017
CURRENT ASSETS:    
Cash and cash equivalents $ 16,064 $ 3,519
Restricted Cash 392 0
Accounts receivable, net 4,151 1,336
Prepaid expenses and other receivables 913 841
GPP receivable 6,600 0
Receivables from related party 0 691
Grants receivable 441 183
Inventory 1,736 725
Total current assets 30,297 7,295
Loan to related party 1,007 0
NON CURRENT ASSETS:    
Bank deposits 85 0
Call option derivative 0 339
Investments in associates, net 0 1,321
Property and equipment, net 11,901 5,104
Intangible assets, net 16,700 15,051
Goodwill 15,165 10,684
Other assets 292 78
Total non-current assets 45,150 32,577
TOTAL ASSETS 75,447 39,872
CURRENT LIABILITIES:    
Accounts payable 3,804 3,914
Accrued expenses and other payables 2,269 1,435
Employees and related payables 3,006 2,961
Related parties 0 116
Advance payments on account of grant 1,724 1,719
Short-term loans and current maturities of long term loans 647 378
Deferred income 5,317 3,611
Current maturities of convertible loans 378 2,780
TOTAL CURRENT LIABILITIES 17,145 16,914
LONG-TERM LIABILITIES:    
Loans payable 1,662 2,118
Convertible loans 1,038 2,415
Retirement benefits obligation 265 6
Deferred taxes 1,702 690
Other long term liabilities 833 0
TOTAL LONG-TERM LIABILITIES 5,500 5,229
TOTAL LIABILITIES 22,645 22,143
COMMITMENTS 0 0
REDEEMABLE NON CONTROLLING INTEREST EQUITY: 24,153 3,606
EQUITY:    
Common stock of $0.0001 par value, 145,833,334 shares authorized, 14,951,783 and 9,872,659 shares issued as of November 30, 2018 and November 30, 2017, respectively 1 1
Additional paid-in capital 88,082 55,334
Receipts on account of shares to be allotted 2,253 1,483
Accumulated other comprehensive income 425 1,425
Accumulated deficit (62,411) (44,120)
Equity attributable to Orgenesis Inc. 28,350 14,123
Non-controlling interests 299 0
TOTAL EQUITY 28,649 14,123
TOTAL LIABILITIES AND EQUITY $ 75,447 $ 39,872